Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 12297

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.41, p 0.279). This receipt's hash covers every field on it, plus the hash of receipt 12296, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 12297
    27 Oct 2026, 21:03 UTC

    PTPRZ1

    oligodendrocytes, braak

    predictionPTPRZ1 in oligodendrocytes tracks Braak Lewy-body stage

    registeredfd38e777fec2eb8b

    discovery-0.41 p=0.279 n=9

    replication-0.04 p=0.912 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.41, p 0.279)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    09d051d607ff6060f21fbedb…
    follows 66b64bf75f6c…

Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next

The swarm's case

receipt 12297: PTPRZ1 in oligodendrocytes, braak

power
full sample -0.22 (p 0.374, n 18), 95% CI -0.62 to +0.27. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.25 (p 0.319, n 18). does not hold up.
composition
oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.20 (p 0.429, n 18). could be the mix.
skeptic
leave-one-out range -0.36 to -0.11, sign flips 0; without severely affected donors -0.22 (p 0.374, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for PTPRZ1 in oligodendrocytes.

case closed: nothing better to follow up.